Cross‐presentation of a CMV pp65 epitope by human dendritic cells using bee venom PLA2 as a membrane‐binding vector
Authors:
- Christine AlmuniaCAChristine Almunia
- Claire BoccaccioCBClaire Boccaccio
- Bruno BeaumelleBBBruno Beaumelle
- Michael H. GelbMGMichael H. Gelb
- André MénezAMAndré Ménez
- Bernard MaillèreBMBernard Maillère
- Jean-Pierre AbastadoJAJean-Pierre Abastado
- Margarita SalcedoMSMargarita Salcedo
- Daniel GilletDGDaniel Gillet
- 19 February 2005
- journal article
- Published by Wiley in FEBS Letters
- Vol. 579 (7) , 1658-1664
Abstract
We have used bee venom phospholipase A2 as a vector to load human dendritic cells ex vivo with a major histocompatibility complex (MHC) class I-restricted epitope fused to its C-terminus. The fusion protein bound to human monocyte-derived dendritic cells and was internalized into early endosomes. In vitro immunization experiments showed that these dendritic cells were able to generate specific CD8 T cell lines against the epitope carried by the fusion protein. Cross-presentation did not require proteasome, transporter associated with antigen processing, or endosome proteases, but required newly synthesized MHC molecules. Comparison of the antigen presentation pathway observed in this study to that followed by other toxins used as vectors is discussed.Keywords
This publication has 35 references indexed in Scilit:
- Alteration of the tertiary structure of the major bee venom allergen Api m 1 by multiple mutations is concomitant with low IgE reactivityProtein Science, 2004
- Secretory phospholipase A2 induces dendritic cell maturationEuropean Journal of Immunology, 2004
- Identification of the Ricin Lipase Site and Implication in CytotoxicityJournal of Biological Chemistry, 2003
- A Serious Adverse Event after Successful Gene Therapy for X-Linked Severe Combined ImmunodeficiencyNew England Journal of Medicine, 2003
- Cross-presentation in viral immunity and self-toleranceNature Reviews Immunology, 2001
- Incoming Human Cytomegalovirus pp65 (UL83) Contained in Apoptotic Infected Fibroblasts Is Cross-Presented to CD8+T Cells by Dendritic CellsJournal of Virology, 2000
- Active Site of Bee Venom Phospholipase A2: The Role of Histidine-34, Aspartate-64 and Tyrosine-87Biochemistry, 1996
- Fine chemical modifications at N- and C-termini enhance peptide presentation to T cells, by increasing the lifespan of both free and MHC-complexed peptidesMolecular Immunology, 1995
- High-level expression in Escherichia coli and rapid purification of enzymatically active honey bee venom phospholipase A2Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1992
- Interfacial catalysis by phospholipase A2: dissociation constants for calcium, substrate, products, and competitive inhibitorsBiochemistry, 1991